APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cabozantinib (Cometriq)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cabozantinib (Cometriq) Industry Growth and Trends Forecast to 2032

23 December 202575 pages

Choose your research edition.

Industry ResearchCabozantinib (Cometriq) Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Cabozantinib (Cometriq) Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Cabozantinib (Cometriq) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cabozantinib (Cometriq) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cabozantinib (Cometriq) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Cabozantinib (Cometriq) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cabozantinib (Cometriq) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cabozantinib (Cometriq) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cabozantinib (Cometriq) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cabozantinib (Cometriq) include Exelixis, Ipsen and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cabozantinib (Cometriq) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cabozantinib (Cometriq) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cabozantinib (Cometriq) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cabozantinib (Cometriq).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cabozantinib (Cometriq) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cabozantinib (Cometriq) Market by Company

Exelixis

Ipsen

Takeda Pharmaceutical

Cabozantinib (Cometriq) Segment by Type

Tablet

Capsule

Cabozantinib (Cometriq) Segment by Application

Medullary Thyroid Cancer

Renal Cell Cancer

Hepatocellular Cancer

Cabozantinib (Cometriq) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cabozantinib (Cometriq) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cabozantinib (Cometriq) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cabozantinib (Cometriq).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cabozantinib (Cometriq) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cabozantinib (Cometriq) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Global Cabozantinib (Cometriq) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cabozantinib (Cometriq) Sales by Type (2021-2026) & (k units) Table 5. Global Cabozantinib (Cometriq) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cabozantinib (Cometriq) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cabozantinib (Cometriq) Sales Market Share in Value by Type (2021-2026) Table 8. Global Cabozantinib (Cometriq) Price by Type (2021-2026) & (USD/unit) Table 9. Global Cabozantinib (Cometriq) Sales by Type (2027-2032) & (k units) Table 10. Global Cabozantinib (Cometriq) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cabozantinib (Cometriq) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cabozantinib (Cometriq) Sales Market Share in Value by Type (2027-2032) Table 13. Global Cabozantinib (Cometriq) Price by Type (2027-2032) & (USD/unit) Table 14. North America Cabozantinib (Cometriq) Sales by Type (2021-2026) & (k units) Table 15. North America Cabozantinib (Cometriq) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cabozantinib (Cometriq) Sales by Type (2021-2026) & (k units) Table 17. Europe Cabozantinib (Cometriq) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cabozantinib (Cometriq) Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Cabozantinib (Cometriq) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cabozantinib (Cometriq) Sales by Type (2021-2026) & (k units) Table 21. Latin America Cabozantinib (Cometriq) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cabozantinib (Cometriq) Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Cabozantinib (Cometriq) Sales by Type (2021-2026) & (US$ Million) Table 24. Cabozantinib (Cometriq) Industry Trends Table 25. Cabozantinib (Cometriq) Industry Drivers Table 26. Cabozantinib (Cometriq) Industry Opportunities and Challenges Table 27. Cabozantinib (Cometriq) Industry Restraints Table 28. Global Cabozantinib (Cometriq) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cabozantinib (Cometriq) Revenue Market Share by Company (2021-2026) Table 30. Global Cabozantinib (Cometriq) Sales by Company (2021-2026) & (k units) Table 31. Global Cabozantinib (Cometriq) Sales Share by Company (2021-2026) Table 32. Global Cabozantinib (Cometriq) Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Cabozantinib (Cometriq) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cabozantinib (Cometriq) Major Company Production Sites and Headquarters Table 35. Global Cabozantinib (Cometriq) Company, Product Type & Application Table 36. Global Cabozantinib (Cometriq) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cabozantinib (Cometriq) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cabozantinib (Cometriq) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cabozantinib (Cometriq) Sales by Region (2021-2026) & (k units) Table 41. Global Cabozantinib (Cometriq) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cabozantinib (Cometriq) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cabozantinib (Cometriq) Sales Market Share in Value by Region (2021-2026) Table 44. Global Cabozantinib (Cometriq) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Cabozantinib (Cometriq) Sales by Region (2027-2032) & (k units) Table 46. Global Cabozantinib (Cometriq) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cabozantinib (Cometriq) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cabozantinib (Cometriq) Sales Market Share in Value by Region (2027-2032) Table 49. Global Cabozantinib (Cometriq) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Cabozantinib (Cometriq) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cabozantinib (Cometriq) Sales by Application (2021-2026) & (k units) Table 52. Global Cabozantinib (Cometriq) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cabozantinib (Cometriq) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cabozantinib (Cometriq) Sales Market Share in Value by Application (2021-2026) Table 55. Global Cabozantinib (Cometriq) Price by Application (2021-2026) & (USD/unit) Table 56. Global Cabozantinib (Cometriq) Sales by Application (2027-2032) & (k units) Table 57. Global Cabozantinib (Cometriq) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cabozantinib (Cometriq) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cabozantinib (Cometriq) Sales Market Share in Value by Application (2027-2032) Table 60. Global Cabozantinib (Cometriq) Price by Application (2027-2032) & (USD/unit) Table 61. North America Cabozantinib (Cometriq) Sales by Application (2021-2026) & (k units) Table 62. North America Cabozantinib (Cometriq) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cabozantinib (Cometriq) Sales by Application (2021-2026) & (k units) Table 64. Europe Cabozantinib (Cometriq) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cabozantinib (Cometriq) Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Cabozantinib (Cometriq) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cabozantinib (Cometriq) Sales by Application (2021-2026) & (k units) Table 68. Latin America Cabozantinib (Cometriq) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cabozantinib (Cometriq) Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Cabozantinib (Cometriq) Sales by Application (2021-2026) & (US$ Million) Table 71. Exelixis Company Information Table 72. Exelixis Business Overview Table 73. Exelixis Cabozantinib (Cometriq) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Exelixis Cabozantinib (Cometriq) Product Portfolio Table 75. Exelixis Recent Development Table 76. Ipsen Company Information Table 77. Ipsen Business Overview Table 78. Ipsen Cabozantinib (Cometriq) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Ipsen Cabozantinib (Cometriq) Product Portfolio Table 80. Ipsen Recent Development Table 81. Takeda Pharmaceutical Company Information Table 82. Takeda Pharmaceutical Business Overview Table 83. Takeda Pharmaceutical Cabozantinib (Cometriq) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Takeda Pharmaceutical Cabozantinib (Cometriq) Product Portfolio Table 85. Takeda Pharmaceutical Recent Development Table 86. North America Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. North America Cabozantinib (Cometriq) Sales by Country (2021-2026) & (k units) Table 88. North America Cabozantinib (Cometriq) Sales Market Share by Country (2021-2026) Table 89. North America Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032) & (k units) Table 90. North America Cabozantinib (Cometriq) Sales Market Share Forecast by Country (2027-2032) Table 91. North America Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Cabozantinib (Cometriq) Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Cabozantinib (Cometriq) Market Share by Country (2021-2026) Table 94. North America Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Cabozantinib (Cometriq) Market Share Forecast by Country (2027-2032) Table 96. Europe Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Europe Cabozantinib (Cometriq) Sales by Country (2021-2026) & (k units) Table 98. Europe Cabozantinib (Cometriq) Sales Market Share by Country (2021-2026) Table 99. Europe Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032) & (k units) Table 100. Europe Cabozantinib (Cometriq) Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Cabozantinib (Cometriq) Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Cabozantinib (Cometriq) Market Share by Country (2021-2026) Table 104. Europe Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Cabozantinib (Cometriq) Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Cabozantinib (Cometriq) Sales by Country (2021-2026) & (k units) Table 108. Asia-Pacific Cabozantinib (Cometriq) Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032) & (k units) Table 110. Asia-Pacific Cabozantinib (Cometriq) Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Cabozantinib (Cometriq) Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Cabozantinib (Cometriq) Market Share by Country (2021-2026) Table 114. Asia-Pacific Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Cabozantinib (Cometriq) Market Share Forecast by Country (2027-2032) Table 116. Latin America Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Latin America Cabozantinib (Cometriq) Sales by Country (2021-2026) & (k units) Table 118. Latin America Cabozantinib (Cometriq) Sales Market Share by Country (2021-2026) Table 119. Latin America Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032) & (k units) Table 120. Latin America Cabozantinib (Cometriq) Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Cabozantinib (Cometriq) Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Cabozantinib (Cometriq) Market Share by Country (2021-2026) Table 124. Latin America Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Cabozantinib (Cometriq) Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Cabozantinib (Cometriq) Sales by Country (2021-2026) & (k units) Table 128. Middle East and Africa Cabozantinib (Cometriq) Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032) & (k units) Table 130. Middle East and Africa Cabozantinib (Cometriq) Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Cabozantinib (Cometriq) Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Cabozantinib (Cometriq) Market Share by Country (2021-2026) Table 134. Middle East and Africa Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Cabozantinib (Cometriq) Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Cabozantinib (Cometriq) Distributors List Table 139. Cabozantinib (Cometriq) Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Cabozantinib (Cometriq) Image Figure 2. Global Cabozantinib (Cometriq) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cabozantinib (Cometriq) Market Size (2021-2032) & (US$ Million) Figure 4. Global Cabozantinib (Cometriq) Sales (2021-2032) & (k units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (k units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Cabozantinib (Cometriq) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cabozantinib (Cometriq) Market Share by Type 2025 VS 2032 Figure 11. North America Cabozantinib (Cometriq) Sales Market Share in Volume by Type in 2025 Figure 12. North America Cabozantinib (Cometriq) Sales Market Share in Value by Type in 2025 Figure 13. Europe Cabozantinib (Cometriq) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cabozantinib (Cometriq) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cabozantinib (Cometriq) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cabozantinib (Cometriq) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cabozantinib (Cometriq) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cabozantinib (Cometriq) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cabozantinib (Cometriq) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cabozantinib (Cometriq) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cabozantinib (Cometriq) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medullary Thyroid Cancer Image Figure 24. Global Medullary Thyroid Cancer Sales YoY Growth (2021-2032) & (k units) Figure 25. Renal Cell Cancer Image Figure 26. Global Renal Cell Cancer Sales YoY Growth (2021-2032) & (k units) Figure 27. Hepatocellular Cancer Image Figure 28. Global Hepatocellular Cancer Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Cabozantinib (Cometriq) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cabozantinib (Cometriq) Market Share by Application 2025 VS 2032 Figure 31. North America Cabozantinib (Cometriq) Sales Market Share in Volume by Application in 2025 Figure 32. North America Cabozantinib (Cometriq) Sales Market Share in Value by Application in 2025 Figure 33. Europe Cabozantinib (Cometriq) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cabozantinib (Cometriq) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cabozantinib (Cometriq) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cabozantinib (Cometriq) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cabozantinib (Cometriq) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cabozantinib (Cometriq) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cabozantinib (Cometriq) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cabozantinib (Cometriq) Sales Market Share in Value by Application in 2025 Figure 41. North America Cabozantinib (Cometriq) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Cabozantinib (Cometriq) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cabozantinib (Cometriq) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cabozantinib (Cometriq) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cabozantinib (Cometriq) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Cabozantinib (Cometriq) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cabozantinib (Cometriq) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cabozantinib (Cometriq) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cabozantinib (Cometriq) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Cabozantinib (Cometriq) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cabozantinib (Cometriq) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cabozantinib (Cometriq) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cabozantinib (Cometriq) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Cabozantinib (Cometriq) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cabozantinib (Cometriq) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cabozantinib (Cometriq) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cabozantinib (Cometriq) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Cabozantinib (Cometriq) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cabozantinib (Cometriq) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cabozantinib (Cometriq) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cabozantinib (Cometriq) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cabozantinib (Cometriq) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Medullary Thyroid Cancer
  • Renal Cell Cancer
  • Hepatocellular Cancer
Companies covered
  • Exelixis
  • Ipsen
  • Takeda Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cabozantinib (Cometriq) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cabozantinib (Cometriq) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cabozantinib (Cometriq) Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.4 Global Cabozantinib (Cometriq) Market Size by Type
  9. 1.4.1 Global Cabozantinib (Cometriq) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cabozantinib (Cometriq) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cabozantinib (Cometriq) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cabozantinib (Cometriq) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cabozantinib (Cometriq) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cabozantinib (Cometriq) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cabozantinib (Cometriq) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cabozantinib (Cometriq) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cabozantinib (Cometriq) Industry Trends
  2. 2.2 Cabozantinib (Cometriq) Industry Drivers
  3. 2.3 Cabozantinib (Cometriq) Industry Opportunities and Challenges
  4. 2.4 Cabozantinib (Cometriq) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cabozantinib (Cometriq) Revenue (2021-2026)
  2. 3.2 Global Top Players by Cabozantinib (Cometriq) Sales (2021-2026)
  3. 3.3 Global Top Players by Cabozantinib (Cometriq) Price (2021-2026)
  4. 3.4 Global Cabozantinib (Cometriq) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cabozantinib (Cometriq) Major Company Production Sites & Headquarters
  6. 3.6 Global Cabozantinib (Cometriq) Company, Product Type & Application
  7. 3.7 Global Cabozantinib (Cometriq) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cabozantinib (Cometriq) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cabozantinib (Cometriq) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cabozantinib (Cometriq) Tier 1, Tier 2, and Tier 3
4 Cabozantinib (Cometriq) Regional Status and Outlook
  1. 4.1 Global Cabozantinib (Cometriq) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cabozantinib (Cometriq) Historic Market Size by Region
  3. 4.2.1 Global Cabozantinib (Cometriq) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cabozantinib (Cometriq) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cabozantinib (Cometriq) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cabozantinib (Cometriq) Forecasted Market Size by Region
  7. 4.3.1 Global Cabozantinib (Cometriq) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cabozantinib (Cometriq) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cabozantinib (Cometriq) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cabozantinib (Cometriq) by Application
  1. 5.1 Cabozantinib (Cometriq) Market by Application
  2. 5.1.1 Medullary Thyroid Cancer
  3. 5.1.2 Renal Cell Cancer
  4. 5.1.3 Hepatocellular Cancer
  5. 5.2 Global Cabozantinib (Cometriq) Market Size by Application
  6. 5.2.1 Global Cabozantinib (Cometriq) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cabozantinib (Cometriq) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cabozantinib (Cometriq) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cabozantinib (Cometriq) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cabozantinib (Cometriq) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cabozantinib (Cometriq) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cabozantinib (Cometriq) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cabozantinib (Cometriq) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Exelixis
  2. 6.1.1 Exelixis Company Information
  3. 6.1.2 Exelixis Business Overview
  4. 6.1.3 Exelixis Cabozantinib (Cometriq) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Exelixis Cabozantinib (Cometriq) Product Portfolio
  6. 6.1.5 Exelixis Recent Developments
  7. 6.2 Ipsen
  8. 6.2.1 Ipsen Company Information
  9. 6.2.2 Ipsen Business Overview
  10. 6.2.3 Ipsen Cabozantinib (Cometriq) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ipsen Cabozantinib (Cometriq) Product Portfolio
  12. 6.2.5 Ipsen Recent Developments
  13. 6.3 Takeda Pharmaceutical
  14. 6.3.1 Takeda Pharmaceutical Company Information
  15. 6.3.2 Takeda Pharmaceutical Business Overview
  16. 6.3.3 Takeda Pharmaceutical Cabozantinib (Cometriq) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Takeda Pharmaceutical Cabozantinib (Cometriq) Product Portfolio
  18. 6.3.5 Takeda Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Cabozantinib (Cometriq) Sales by Country
  2. 7.1.1 North America Cabozantinib (Cometriq) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cabozantinib (Cometriq) Sales by Country (2021-2026)
  4. 7.1.3 North America Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cabozantinib (Cometriq) Market Size by Country
  6. 7.2.1 North America Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cabozantinib (Cometriq) Market Size by Country (2021-2026)
  8. 7.2.3 North America Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cabozantinib (Cometriq) Sales by Country
  2. 8.1.1 Europe Cabozantinib (Cometriq) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cabozantinib (Cometriq) Sales by Country (2021-2026)
  4. 8.1.3 Europe Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cabozantinib (Cometriq) Market Size by Country
  6. 8.2.1 Europe Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cabozantinib (Cometriq) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cabozantinib (Cometriq) Sales by Country
  2. 9.1.1 Asia-Pacific Cabozantinib (Cometriq) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cabozantinib (Cometriq) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cabozantinib (Cometriq) Market Size by Country
  6. 9.2.1 Asia-Pacific Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cabozantinib (Cometriq) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cabozantinib (Cometriq) Sales by Country
  2. 10.1.1 South America Cabozantinib (Cometriq) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cabozantinib (Cometriq) Sales by Country (2021-2026)
  4. 10.1.3 South America Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cabozantinib (Cometriq) Market Size by Country
  6. 10.2.1 South America Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cabozantinib (Cometriq) Market Size by Country (2021-2026)
  8. 10.2.3 South America Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cabozantinib (Cometriq) Sales by Country
  2. 11.1.1 Middle East and Africa Cabozantinib (Cometriq) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cabozantinib (Cometriq) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cabozantinib (Cometriq) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cabozantinib (Cometriq) Market Size by Country
  6. 11.2.1 Middle East and Africa Cabozantinib (Cometriq) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cabozantinib (Cometriq) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cabozantinib (Cometriq) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cabozantinib (Cometriq) Value Chain Analysis
  2. 12.1.1 Cabozantinib (Cometriq) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cabozantinib (Cometriq) Production Mode & Process
  7. 12.2 Cabozantinib (Cometriq) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cabozantinib (Cometriq) Distributors
  10. 12.2.3 Cabozantinib (Cometriq) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst